Cell and gene therapy firm raises $170M investment

ElevateBio, a cell and gene therapy holding company created by former executives from Alexion Pharmaceuticals and bluebird bio, is set to move six drugs to clinical trials after raising new financing.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.